Mitigating the Risk of Skeletal Events in Metastatic Renal Cell Carcinoma.
Bone metastases affect approximately one-third of patients with metastatic renal cell carcinoma (mRCC) and contribute to substantial skeletal complications and shorter survival. Management of these metastases requires a multidisciplinary approach combining …